Learn more at HyposMatter.com

Visit HyposMatter.com

CLICK HERE >>

Hypoglycemia Is the Major Limiting Factor in Glycemic Control1

Achieving glycemic control without hypoglycemia is a balancing act. Intensive therapy often increases the risk of hypoglycemia1,2

HyposMatter.com provides users with an overview of hypoglycemia as a barrier to glucose control, the direct economic impact of hypoglycemia, and consequences associated with hypoglycemia

CLICK HERE >>

to visit HyposMatter.com and learn more!

You May Only Be Seeing the Tip of the Iceberg -
the Consequences of Hypoglycemia Present a Considerable Clinical and Economic Burden

Hypoglycemia is a barrier to glucose control1,3

Severe hypoglycemic events are costly to manage4,5

The consequences associated with hypoglycemia lie beneath the surface6

CLICK HERE >>

to learn more about hypoglycemia and how it impacts glucose control, costs, and consequences

A1C=glycated hemoglobin.
References: 1. American Diabetes Association. Standards of medical care in diabetes - 2018. Diabetes Care. 2018;41(suppl 1):S1-S159. 2. DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med. 1991;90(4):450-459. 3. Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health. 2011;14(5):665-671. 4. Heller SR, Frier BM, Hersløv ML, Gundgaard J, Gough SC. Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources. Diabet Med. 2016;33(4):471-477. 5. Ward A, Alvarez P, Vo L, Martin S. Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012). J Med Econ. 2014;17(3):176-183. 6. Frier BM. The economic costs of hypoglycaemia. Br J Diabetes Vasc Dis. 2011;11(suppl 1):S10-S12.

To ensure receipt of future emails, please add novonordisk@email.novonordiskmail.com to your address book.

Please do not respond to this email. If you would like to contact us, please click here or call 1-800-727-6500.

UNSUBSCRIBE NOTICE
To unsubscribe from future communications from Novo Nordisk Inc., please click here. Additionally, you can unsubscribe from future Novo Nordisk communications by calling 1-877-744-2579 or sending a brief note with your name and address to Novo Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey 08536.

Novo Nordisk logo

Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2018 Novo Nordisk All rights reserved. US18DI00011 May 2018

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.